Asthma

The Pharmacy Times® Asthma resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

What can we help you find?
[[thumbnail_alt_text]]
As a chronic respiratory disease, asthma has been considered a risk factor for COVID-19 by many experts and clinicians.
 
[[thumbnail_alt_text]]
The inhaler sends data back to a mobile app in real time.
[[thumbnail_alt_text]]
Contrary to World Health Organization recommendations, the benefits of steroids used in inhalers and nebulizers outweigh the risks. 

 
[[thumbnail_alt_text]]
The dupilumab pen features a hidden needle and single-press auto-injection, along with visual and audio feedback to help with administration.
[[thumbnail_alt_text]]
Generic products featured in the May 2020 issue.
[[thumbnail_alt_text]]
Patients with COVID-19 between the ages of 20 and 59 years who also had asthma needed a ventilator to assist with breathing for 5 days more on average than non-asthmatic patients with COVID-19, according to a press release.
[[thumbnail_alt_text]]
The National Institutes of Health (NIH) has issued a timely statement emphasizing the importance of asthma awareness and standing with parents, families, advocates, researchers, and health care professionals.
[[thumbnail_alt_text]]
A study to help determine the incidence rate of the coronavirus disease 2019 (COVID-19) in children and their family members has begun enrolling participants in the United States, according to the National Institutes of Health (NIH).
[[thumbnail_alt_text]]
Pharmacists should understand their mechanisms to facilitate high-quality, collaborative management with physicians.
[[thumbnail_alt_text]]
Pharmacists can educate patients about the nonprescription asthma inhaler that recently returned to the market.
[[thumbnail_alt_text]]
The American Lung Association (ALA) has started a $25M initiative to address the coronavirus disease 2019 (COVID-19) pandemic and other future respiratory virus pandemics.
 
[[thumbnail_alt_text]]
This medication inhaler is indicated for the treatment or prevention of bronchospasm in patients ages 4 years and older who have reversible obstructive airway disease.